TY  - CONF

T1  - 1533 A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: efficacy and safety results from the open-label phase 2 SCOPE trial

JO  - Late-Breaking Abstracts

UR  - http://dx.doi.org/10.1136/jitc-2023-sitc2023.1533

PY  - 2023/10/31

AU  - Shaw H

AU  - Patel P

AU  - Payne M

AU  - Kumar S

AU  - Danson S

AU  - Highley M

AU  - Barlow C

AU  - Miller R

AU  - Master F

AU  - Durrant L

ED  - 

DO  - DOI: 10.1136/jitc-2023-sitc2023.1533

PB  - BMJ Publishing Group Ltd

Y2  - 2024/09/19

ER  -